Stocks and Investing Stocks and Investing
Fri, November 17, 2023
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (AKBA) at Strong Buy with Increased Target to $5 on, Nov 17th, 2023
Thu, November 16, 2023
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AIRS) at Hold with Decreased Target to $6 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
David Saxon Maintained (ALC) at Strong Buy with Decreased Target to $86 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Chris Kotowski Maintained (BAC) at Buy with Increased Target to $51 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Allen Klee Downgraded (AUUD) to Hold on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Nicolas Cote-Colisson Downgraded (ATUS) to Sell and Decreased Target to $1.2 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (APA) at Hold with Decreased Target to $42 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Scott Hanold Reiterated (APA) at Hold and Held Target at $50 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Craig Ellis Initiated (AMKR) at Strong Buy and Held Target at $35 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Bill Sutherland Reiterated (BEAT) at Buy and Held Target at $8 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Steve Powers Maintained (BF) at Hold with Decreased Target to $63 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (BFH) at Hold with Decreased Target to $31 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Clarke Jeffries Reiterated (BIGC) at Hold and Held Target at $11 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Chris Kotowski Maintained (C) at Buy with Increased Target to $85 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Kevin Heal Downgraded (CBOE) to Hold on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Ali Faghri Upgraded (BWA) to Strong Buy on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Jayson Bedford Downgraded (BWAY) to Hold on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Steven Lichtman Maintained (BWAY) at Buy with Increased Target to $6 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (BSM) at Hold with Increased Target to $17 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (BRY) at Hold with Decreased Target to $8 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Elizabeth Suzuki Downgraded (AAP) to Sell and Decreased Target to $43 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Kate McShane Maintained (AAP) at Hold with Decreased Target to $73 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Seth Basham Maintained (AAP) at Hold with Decreased Target to $60 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (AAP) at Hold with Decreased Target to $55 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Michael Lasser Maintained (AAP) at Hold with Decreased Target to $62 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Seth Sigman Maintained (AAP) at Hold with Decreased Target to $56 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Catharine Trebnick Maintained (ZS) at Strong Buy with Increased Target to $225 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Omar Nokta Maintained (ZIM) at Hold with Decreased Target to $8 on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
David Saxon Initiated (ZIMV) at Hold on, Nov 16th, 2023
[ 12:00 AM ] - WOPRAI
Ross Osborn Maintained (VNRX) at Buy with Increased Target to $2.5 on, Nov 16th, 2023

Ross Osborn Maintained (VNRX) at Buy with Increased Target to $2.5 on, Nov 16th, 2023


Published on 2024-10-28 07:37:53 - WOPRAI, Ross Osborn
  Print publication without navigation


Ross Osborn of Cantor Fitzgerald, Maintained "VolitionRx Limited" (VNRX) at Buy with Increased Target from $2.1 to $2.5 on, Nov 16th, 2023.

Ross has made no other calls on VNRX in the last 4 months.



There are 2 other peers that have a rating on VNRX. Out of the 2 peers that are also analyzing VNRX, 0 agree with Ross's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ross

  • Tim Moore of "EF Hutton" Initiated at Strong Buy and Held Target at $4.5 on, Monday, October 30th, 2023
  • Kyle Mikson of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $2 on, Wednesday, August 16th, 2023
Contributing Sources